CORNEAL HEALTH BIOLOGICS
At MellingMedical, we value the strength of our relationship with CorneaGen, a mission-driven ophthalmic company specializing in corneal health. Founded in 2016, CorneaGen emerged as a for-profit subsidiary of SightLife, with a clear mission to eliminate corneal blindness by 2040. Headquartered in Seattle, Washington, CorneaGen has earned recognition as a prominent provider of donor corneal tissue and developer of cutting-edge surgical devices for corneal transplantation, particularly in the realm of biologics and wound care.
CorneaGen’s expertise lies in its comprehensive approach to cornea care. The company offers advanced corneal tissue options like DMEK and DSEK, pre-cut and pre-shaped for partial-thickness transplants, enhancing visual outcomes and recovery times. Their Nano-Thin DSEK sets a new standard with its extremely thin grafts. Additionally, CorneaGen has introduced CTAK (Corneal Tissue Addition for Keratoplasty), a patient-specific inlay for reshaping the cornea in keratoconus cases, reducing the need for full transplants.
Their surgical devices, such as the EndoSerter-PL and Geuder Pre-Loaded Glass Cannula, are designed to assist surgeons in performing delicate procedures with precision and minimal tissue handling. Moreover, CorneaGen provides sterile tissue solutions, crucial for applications in glaucoma and emergency corneal repairs, through gamma-irradiated products like VisionGraft.
CorneaGen frequently pushes the boundaries of corneal health innovation. They were pioneers in introducing Amphotericin-B, an antifungal additive in storage media. Their support extends to the development of alternative treatments through organizations like Aurion Biotech. With an expansive network of labs and a distribution footprint reaching over 50 countries, CorneaGen demonstrates a sustained commitment to advancing corneal health worldwide.
STRUCTURED PROCUREMENT ACCESS
MellingMedical is committed to facilitating access to vital healthcare innovations, such as those offered by CorneaGen, through structured and compliant procurement pathways. By partnering with us, our suppliers help ensure federal healthcare facilities gain streamlined access to advanced biologics and wound care solutions essential for treating veterans and contributing to public health.
Our expertise in navigating the complexities of federal healthcare procurement ensures that medical professionals have timely availability of CorneaGen’s specialized products, optimizing patient outcomes. As a Service-Disabled Veteran-Owned Small Business, MellingMedical is uniquely positioned to support federal entities in incorporating these life-enhancing technologies into their care offerings, reinforcing our commitment to excellence in healthcare services.